{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "7 HonorHealth Research Institute, Scottsdale, Arizona, USA",
    "University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, USA",
    "Caris Life Sciences Inc Arizona Office/Labs, Phoenix, Arizona, USA",
    "Clinical and Translational Research, Caris Life Sciences, Phoenix, Arizona, USA",
    "3 Clinical & Translational Research, Medical Affairs, Caris Life Sciences, Caris Life Sciences, Phoenix, Arizona, USA",
    "5UCI Health Chao Family Comprehensive Cancer Center, Irvine, CA, USA",
    "USC Norris Comprehensive Cancer Center, Los Angeles, CA, USA",
    "University of Miami, Miami, FL, USA",
    "CARIS Life Sciences, Phoenix, AZ, USA",
    "University of Miami - School of Medicine, Miami, FL, USA"
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 10,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Justin Moser"
    },
    {
      "affs": [
        1
      ],
      "name": "Jose Lutzky"
    },
    {
      "affs": [
        2
      ],
      "name": "Andrew Elliott"
    },
    {
      "affs": [
        3
      ],
      "name": "Yasmine Baca"
    },
    {
      "affs": [
        4
      ],
      "name": "Nishant Gandhi"
    },
    {
      "affs": [
        5
      ],
      "name": "Poorva Vaidya"
    },
    {
      "affs": [
        6
      ],
      "name": "Gino K In"
    },
    {
      "affs": [
        7
      ],
      "name": "Clara J Oh"
    },
    {
      "affs": [
        8
      ],
      "name": "Jingshu Chen"
    },
    {
      "affs": [
        9
      ],
      "name": "Garrett Kraft"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/1qqxaynxyxnz2.bib",
  "cited_by": 0,
  "doi": "10.1136/jitc-2026-sitc2026.0114",
  "fulltext_url": null,
  "id": "1qqxaynxyxnz2",
  "issns": [
    "2051-1426"
  ],
  "landing_url": "https://doi.org/10.1136/jitc-2026-sitc2026.0114",
  "language": "en",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "journal",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "lcc",
      "RC254-282"
    ],
    [
      "openalex",
      "2731|Ocular Oncology and Treatments"
    ]
  ],
  "openalex": "W7225157331",
  "pdf_url": "https://jitc.bmj.com/content/14/Suppl_2/A121.full.pdf",
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-06",
  "publisher": "BMJ Publishing Group",
  "ris": "https://research.draconitic.com/paper/1qqxaynxyxnz2.ris",
  "sources": [
    {
      "first_seen": "2026-11-07T14:21:03Z",
      "native_id": "8878e96cc6f742d1b14b2409014fadb1",
      "source": "doaj",
      "url": "https://doi.org/10.1136/jitc-2026-sitc2026.0114"
    }
  ],
  "subjects": [
    {
      "field": "biology",
      "origin": "journal-openalex:2403|Immunotherapy and Immune Responses",
      "subfield": "immunology"
    },
    {
      "field": "medicine",
      "origin": "lcc:RC254-282",
      "subfield": "oncology"
    }
  ],
  "title": "114 CXCL6 emerges as a novel marker of an immunosuppressive, angiogenic, and epithelial-mesenchymal transition (EMT)-enriched metastatic program in uveal melanoma (UM)",
  "title_text": "114 CXCL6 emerges as a novel marker of an immunosuppressive, angiogenic, and epithelial-mesenchymal transition (EMT)-enriched metastatic program in uveal melanoma (UM)",
  "type": "peer-reviewed",
  "updated_at": "2026-11-08T14:20:31Z",
  "url": "https://research.draconitic.com/paper/1qqxaynxyxnz2",
  "venue": "Journal for ImmunoTherapy of Cancer",
  "versions": []
}